View Item 

Show simple item record

Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis

dc.contributor.authorMiceli, Marisa H.en_US
dc.contributor.authorGoggins, Michael I.en_US
dc.contributor.authorChander, Pranayen_US
dc.contributor.authorSekaran, Archana K.en_US
dc.contributor.authorKizy, Anne E.en_US
dc.contributor.authorSamuel, Linojen_US
dc.contributor.authorJiang, Huien_US
dc.contributor.authorThornton, Christopher R.en_US
dc.contributor.authorRamesh, Mayuren_US
dc.contributor.authorAlangaden, Georgeen_US
dc.date.accessioned2015-06-01T18:51:31Z
dc.date.available2016-07-05T17:27:57Zen
dc.date.issued2015-06en_US
dc.identifier.citationMiceli, Marisa H.; Goggins, Michael I.; Chander, Pranay; Sekaran, Archana K.; Kizy, Anne E.; Samuel, Linoj; Jiang, Hui; Thornton, Christopher R.; Ramesh, Mayur; Alangaden, George (2015). "Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis." Mycoses 58(6): 368-374.en_US
dc.identifier.issn0933-7407en_US
dc.identifier.issn1439-0507en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/111755
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherdiagnosisen_US
dc.subject.otherAspergillusen_US
dc.subject.otherlateral flow deviceen_US
dc.subject.otherbrochoalveolar lavageen_US
dc.titlePerformance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDentistryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/111755/1/myc12327.pdf
dc.identifier.doi10.1111/myc.12327en_US
dc.identifier.sourceMycosesen_US
dc.identifier.citedreferenceCahill BC, Hibbs JR, Savik K et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997; 112: 1160 – 4.en_US
dc.identifier.citedreferenceThompson GR, 3rd, Patterson TF. Pulmonary aspergillosis. Semin Respir Crit Care Med 2008; 29: 103 – 10.en_US
dc.identifier.citedreferenceMarr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909 – 17.en_US
dc.identifier.citedreferenceSingh N, Husain S. AST Infectious Diseases Community of Practice. Aspergillosis in solid organ transplantation. Am J Transplant 2013; 13: 228 – 41.en_US
dc.identifier.citedreferencevon Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341 – 7.en_US
dc.identifier.citedreferenceCaillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253 – 9.en_US
dc.identifier.citedreferenceDe Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813 – 21.en_US
dc.identifier.citedreferenceMennink‐Kersten MA, Verweij PE. Non‐culture‐based diagnostics for opportunistic fungi. Infect Dis Clin North Am 2006; 20: 711 – 27.en_US
dc.identifier.citedreferenceZou M, Tang L, Zhao S et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS ONE 2012; 7: e43347.en_US
dc.identifier.citedreferenceThornton CR. Development of an immunochromatographic lateral‐flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 2008; 15: 1095 – 105.en_US
dc.identifier.citedreferenceThornton CR. Detection of invasive aspergillosis. Adv Applied Microbiol 2010; 70: 187 – 216.en_US
dc.identifier.citedreferenceHoenigl M, Koidl C, Duettmann W et al. Bronchoalveolar lavage lateral‐flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infection 2012; 65: 588 – 91.en_US
dc.identifier.citedreferenceHoenigl M, Prattes J, Spiess B et al. Performance of galactomannan, beta‐d‐glucan, Aspergillus lateral‐flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2014; 52: 2039 – 45.en_US
dc.identifier.citedreferenceWillinger B, Lackner M, Lass‐Florl C et al. Bronchoalveolar lavage lateral‐flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study. Transplantation 2014; 98: 898 – 902.en_US
dc.identifier.citedreferenceRüping MJGT, Vehreschild JJ, Cornely OA. Patients at high risk of invasive fungal infection: when and how to treat. Drugs 2008; 68: 1941 – 62.en_US
dc.identifier.citedreferenceThornton CR. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral flow technology. J Vis Exp 2012; 61: 1 – 5.en_US
dc.identifier.citedreferenceSilveira FP, Husain S. Fungal infections in lung transplant recipients. Curr Opin Pulm Med 2008; 14: 211 – 8.en_US
dc.identifier.citedreferenceFood and Drug Administration ‐ Detection of galactomannan in serum. [WWW document], URL http://www.accessdata.fda.gov/cdrh_docs/pdf9/K093678.pdf 2011 [accessed on 26 January 2013].en_US
dc.identifier.citedreferenceFood and Drug Administration ‐ Detection of galactomannan in bronchoalveolar lavage. [WWW document], http://www.accessdata.fda.gov/cdrh_docs/pdf6/K060641.pdf 2006 [accessed on 26 January 2013].en_US
dc.identifier.citedreferenceHope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609 – 22.en_US
dc.identifier.citedreferenceHusain S, Paterson DL, Studer SM et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007; 83: 1330 – 6.en_US
dc.identifier.citedreferenceSwanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme‐linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257 – 60.en_US
dc.identifier.citedreferenceKappe R, Schulze‐Berge A. New cause for false‐positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993; 31: 2489 – 90.en_US
dc.identifier.citedreferenceClancy CJ, Jaber RA, Leather HL et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid‐organ transplant recipients. J Clin Microbiol 2007; 45: 1759 – 65.en_US
dc.identifier.citedreferenceWheat LJ, Nguyen MH, Alexander B et al. Long‐term stability at −20°C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens. J Clinc Microbiol 2014; 52: 2108 – 11.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
myc12327.pdf
Size:
216.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.